Literature DB >> 17506818

Innate immunity to respiratory viruses.

Jennifer P Wang1, Evelyn A Kurt-Jones, Robert W Finberg.   

Abstract

Pattern recognition receptors are critically involved in the development of innate and adaptive antiviral immunity. Innate immune activation by viruses may occur via cell surface, intracellular and cytosolic pattern recognition receptors. These receptors sense viral components and may activate unique downstream pathways to generate antiviral immunity. In this article, we summarize the pattern recognition receptors that recognize major human respiratory viral pathogens, including influenza virus, respiratory syncytial virus and adenovirus. We also provide an overview of the current knowledge of regulation of type I interferons and inflammatory cytokines in viral infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506818     DOI: 10.1111/j.1462-5822.2007.00961.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  23 in total

1.  Limited replication of influenza A virus in human mast cells.

Authors:  Candy W Marcet; Chris D St Laurent; Tae Chul Moon; Nav Singh; A Dean Befus
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

2.  Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures.

Authors:  William A Fischer; Kelly D Chason; Missy Brighton; Ilona Jaspers
Journal:  Vaccine       Date:  2014-01-30       Impact factor: 3.641

3.  Discovery of a novel TLR2 signaling inhibitor with anti-viral activity.

Authors:  Shenghua Zhou; Anna M Cerny; Glennice Bowen; Melvin Chan; David M Knipe; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  Antiviral Res       Date:  2010-07-23       Impact factor: 5.970

4.  Increased pro-inflammatory cytokine production in Down Syndrome children upon stimulation with live influenza A virus.

Authors:  Chantal J M Broers; Reinoud J B J Gemke; Michel E Weijerman; Koen F van der Sluijs; A Marceline van Furth
Journal:  J Clin Immunol       Date:  2011-12-15       Impact factor: 8.317

Review 5.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 6.  New insights into the aryl hydrocarbon receptor as a modulator of host responses to infection.

Authors:  B Paige Lawrence; Beth A Vorderstrasse
Journal:  Semin Immunopathol       Date:  2013-08-21       Impact factor: 9.623

7.  Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection.

Authors:  Stephan W Glasser; Teah L Witt; Albert P Senft; John E Baatz; Dusti Folger; Melissa D Maxfield; Henry T Akinbi; Danforth A Newton; Daniel R Prows; Thomas R Korfhagen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-20       Impact factor: 5.464

8.  Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice.

Authors:  Victoria Jeisy-Scott; William G Davis; Jenish R Patel; John Bradford Bowzard; Wun-Ju Shieh; Sherif R Zaki; Jacqueline M Katz; Suryaprakash Sambhara
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

9.  Genetics, recombination and clinical features of human rhinovirus species C (HRV-C) infections; interactions of HRV-C with other respiratory viruses.

Authors:  Anne Wisdom; Aldona E Kutkowska; E Carol McWilliam Leitch; Eleanor Gaunt; Kate Templeton; Heli Harvala; Peter Simmonds
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

Review 10.  Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2.

Authors:  Diego Fernández-Lázaro; Cesar I Fernandez-Lazaro; Juan Mielgo-Ayuso; David P Adams; Juan Luis García Hernández; Jerónimo González-Bernal; Marcela González-Gross
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.